SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)
PFE 25.04+2.6%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anthony Wong who wrote (1151)11/25/1998 4:13:00 PM
From: Anthony Wong  Read Replies (2) of 1722
 
[Rhone-Poulenc, PFE]11/25 15:56 No science to back EU antibiotic ban -thinktank

BRUSSELS, Nov 25 (Reuters) - A Dutch thinktank said on Wednesday a
proposed European Union ban on the use of antibiotic growth promoters in
livestock because of the effect they could have on humans was not justified on
the basis of scientific data.

"The gap between the need for some policy concerning the use of antibiotic
growth promoters and the lack of factual data concerning direct resistance
transfer from animals to humans is bridged by the so-called 'precautionary
principle'," Jaap Hanekamp, co-author of a report by Heidelberg Appeal
Nederlands (HAN) into growth promoters, said in a statement.

The statement was issued by the European Federation of Animal Health and the
European Federation of Animal Feed Additive Manufacturers (Fefana).

"However, (this) principle...can only serve its function here when reasonable
doubts concerning certain human health risks...is substantiated by hard scientific
data. In this case, these data are unfortunately lacking," Hanekamp said.

The statement said HAN is a non-profit making alliance of scientists and
science supporters. Hanekamp said the study was paid for by Fefana.

The EU executive European Commission proposed banning four antibiotics in
animal feed on November 12. It is to be considered by a panel of EU scientists
next month and could take effect in January.

Among manufacturers whose sales could be affected by any ban are France's
Rhone-Poulenc <RHON.PA> and Pfizer <PFE.N> of the United States.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext